2026 ISHLT Infectious Disease/Pharmacy Academy: From Pathogens to Pharmacokinetics - Optimizing Outcomes in Thoracic Transplant

Register Now

21 April, 2026 8:00 a.m. to 5:30 p.m. EDT

Metro Toronto Convention Centre, Toronto, ON Canada
  • Academy
  • Advanced Heart Failure & Transplantation
  • Advanced Lung Failure & Transplantation
  • Education
  • In Person Education
  • Infectious Diseases
  • ISHLT2026
  • Mechanical Circulatory Support
  • Pharmacy
2026 ISHLT ID/PHARM Academy

Download the Preliminary Program for detailed course topics, learning objectives, and information on the target audience for this course.

Preliminary Program

This comprehensive full-day course provides transplant clinicians, pharmacists, and multidisciplinary care teams with an in-depth, case-based review of the most critical and evolving aspects of infectious diseases and immunology in heart and lung transplantation. Through expert-led presentations and interactive discussions, participants will explore:

  • Preventing, detecting, and managing immunologic complications in transplant
  • Optimizing antimicrobial, antiviral, and antifungal therapies
  • Evaluating infectious risks in donor and recipient scenarios—and standardized approaches to manage these risks
  • Vaccines, peri-transplant prophylaxis, and molecular diagnostics

This course is designed for transplant clinicians, pharmacists, and specialists on care teams treating infectious diseases in heart and lung transplant patients.

Academy Chairs

Headshot of Fay BurrowsFay Burrows, BPharm
St Vincent's Hospital
Darlinghurst, Australia
Jennifer Chow HeadshotJennifer Chow, MD, MS
Tufts Medical Center
Boston, MA, USA
Headshot of Patricia GingPatricia Ging, BPharm, MSc
Atlantic Technological University
Stigo, Ireland
Headshot of Bradley GardinerBrad Gardiner, MBBS, FRACP, MS, PhD
Alfred Health/Monash University
Melbourne, QLD Australia
Headshot of Daryl NnaniDaryl Nnani, PharmD, BCTXP
Montefiore Medical Center
Bronx, NY, USA
 
Academy Faculty

Daniel Calabrese, MD, University of California, San Francisco, San Francisco, CA USA
Lilibeth Carlos, BPharm, St. Vincent's Hospital Sydney, Sydney, NSW Australia
Bailey Colvin, PharmD, West Virginia University Medicine, Ruby Memorial Hospital, Morgantown, WV USA
Lara Danziger-Isakov, MD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH USA
Sara Farghaly, PharmD, Montefiore Medical Center, Bronx, NY USA
Jens Gottlieb, MD, Hannover Medical School, Hannover, Germany
Courtney Harris, MD, Medical University of South Carolina, Charleston, SC USA
Ed Horn, PharmD, University of Pittsburgh, Pittsburgh, PA USA
Dima Kabbani, MD, MSc, University of Alberta, Edmonton, AB Canada
Andrew Karaba, MD, PhD, John Hopkins University, Baltimore, MD USA
Rebecca Kumar, MD, Georgetown University Medical Center, Washington, DC USA
Asbjorn Lunnan, PharmD, Oslo University Hospital, Oslo, Norway
Aaron Mishkin, MD, Temple University Hospital, Philadelphia, PA USA
Maddy Morrison, PharmD, BCTXP, Vanderbilt University Medical Center, Nashville, TN USA
Nicolas Muller, MD, University Hospital Zurich, Zurich, Switzerland
Kavitha Muthiah, MCChB, PhD, St. Vincent's Hospital Sydney, Sydney, NSW Australia
Yoichiro Natori, MD, MPH, University of Miami, Miami, FL USA
Elena Seminari, MD, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Miranda So, PharmD, MPH, BScPhm, University Health Network, Toronto, ON Canada
Valentina Stosor, MD, Northwestern University Feinberg School of Medicine, Chicago, IL USA
Patrick Tam, MBBS, MIPH, Duke University Hospital, Durham, NC USA
Ann Woolley, MD, MPH, Brigham & Women's Hospital, Boston, MA USA